“Weeding out the competition” – an update on M&A activity in the cannabis sector

By Troy Ungerman (Toronto) on August 21, 2019 Posted in Cannabis, M&A

As discussed in previously, the legalization of cannabis in October 2018 sparked a flurry of activity in the Canadian market, as both foreign and domestic investors were eager to enter the space. Notably, in 2018, M&A transactions peaked with over 700 deals completed in the cannabis sector, the total value of which exceeded US$12 billion. … Continue reading

Spreading like weeds: alternative cannabis products are on the way!

By Troy Ungerman (Toronto) on June 13, 2019 Posted in Antitrust, competition and regulatory, Cannabis, M&A

As we have previously discussed, Canada has positioned itself as a global leader in the cannabis space. That trend is set to continue on October 17, 2019, when it is expected that alternative cannabis products, which include edibles, infused beverages and topicals containing cannabis and cannabis concentrates will be legalized in Canada. The sale of a new and wider … Continue reading

Health Canada changes cannabis licensing process

By Troy Ungerman (Toronto) on May 16, 2019 Posted in Cannabis, M&A, Pharmaceuticals and life sciences

On May 8, 2019, Health Canada announced that it is introducing changes to its cannabis licensing process, effective immediately. Before the change, an applicant can apply for a cannabis license by submitting paper application to Health Canada without having to build a facility first. Now, a new applicant for licence to cultivate, process or sell … Continue reading